lobbying_activities: 1007692

Individual lobbying activities reported in quarterly filings. Each row is one issue area for one client — includes the specific issues lobbied on, government entities contacted, and income/expense amounts.

Data license: Public Domain (U.S. Government data) · Data source: Federal Register API & Regulations.gov API

This data as json

id	filing_uuid	filing_type	registrant_name	registrant_id	client_name	filing_year	filing_period	issue_code	specific_issues	government_entities	income_amount	expense_amount	is_no_activity	is_termination	received_date
1007692	31b03ed6-ff6d-49c3-8871-ef8e512a4ed1	Q3	WINSTON & STRAWN LLP	41682	FRESENIUS KABI USA (FORMERLY KNOWN AS APP PHARMACEUTICALS INC )	2010	third_quarter	PHA	Represent the client on issues related to assuring a safe, reliable supply of heparin and also patent matters, including settlements. Legislation of interest includes the FY 2011 Financial Services Appropriations Bill (S. 3677), the FY 2010 Supplemental Appropriations Bill (H.R. 4899; P.L. 111-212), and the Preserve Access to Affordable Generics Act (S. 369).	HOUSE OF REPRESENTATIVES,SENATE	20000		0	0	2010-10-19T18:27:45.003000-04:00